Cargando…
Shigatoxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapies
Hemolytic uremic syndrome is the leading cause of acute kidney injury in childhood. Ninety percent of cases are secondary to gastrointestinal infection with shigatoxin-producing bacteria. In this review, we discuss the molecular mechanisms of shigatoxin leading to hemolytic uremic syndrome and the e...
Autores principales: | Keir, Lindsay S, Marks, Stephen D, Kim, Jon Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3414372/ https://www.ncbi.nlm.nih.gov/pubmed/22888220 http://dx.doi.org/10.2147/DDDT.S25757 |
Ejemplares similares
-
Pharmacological Management of Atypical Hemolytic Uremic Syndrome in Pediatric Patients: Current and Future
por: Gurevich, Evgenia, et al.
Publicado: (2023) -
Hemolytic uremic syndrome.
por: Beers, M, et al.
Publicado: (1995) -
Atypical hemolytic uremic syndrome
por: Loirat, Chantal, et al.
Publicado: (2011) -
Recurrent hemolytic uremic syndrome
por: Lakshminarayana, G., et al.
Publicado: (2008) -
Atypical Hemolytic Uremic Syndrome
por: Kavanagh, David, et al.
Publicado: (2013)